0
0
10/11/23 at 10:00am
Organization
PRNewswire
44 words
0
Comments
/PRNewswire/ -- In fall of 2022, the United States saw an early and significant spike in cases of Respiratory Syncytial Virus, or RSV, which is the leading...
You are the first to view
https://www.prnewswire.com/news-releases/4-common-questions-answered-about-the-new-monoclonal-antibody-to-help-prevent-severe-rsv-in-babies-301952932.html
Create an account
or login to join the discussion